manuela merli
manuela merli
Universita' Sapienza di Roma
Nessuna email verificata
TitoloCitata daAnno
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial
G Marchesini, G Bianchi, M Merli, P Amodio, C Panella, C Loguercio, ...
Gastroenterology 124 (7), 1792-1801, 2003
Incidence and natural history of small esophageal varices in cirrhotic patients
M Merli, G Nicolini, S Angeloni, V Rinaldi, A De Santis, C Merkel, AF Attili, ...
Journal of hepatology 38 (3), 266-272, 2003
ESPEN guidelines for nutrition in liver disease and transplantation
M Plauth, M Merli, J Kondrup, A Weimann, P Ferenci, MJ Mller, ...
Clinical nutrition 16 (2), 43-55, 1997
Factors associated with poor health-related quality of life of patients with cirrhosis
G Marchesini, G Bianchi, P Amodio, F Salerno, M Merli, C Panella, ...
Gastroenterology 120 (1), 170-178, 2001
Does malnutrition affect survival in cirrhosis?
M Merli, O Riggio, L Dally
Hepatology 23 (5), 1041-1046, 1996
Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
F Salerno, M Merli, O Riggio, M Cazzaniga, V Valeriano, M Pozzi, ...
Hepatology 40 (3), 629-635, 2004
MELD score is better than Child–Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt
F Salerno, M Merli, M Cazzaniga, V Valeriano, P Rossi, A Lovaria, ...
Journal of hepatology 36 (4), 494-500, 2002
Cirrhotic patients are at risk for health care–associated bacterial infections
M Merli, C Lucidi, V Giannelli, M Giusto, O Riggio, M Falcone, L Ridola, ...
Clinical Gastroenterology and Hepatology 8 (11), 979-985. e1, 2010
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts
O Riggio, S Angeloni, FM Salvatori, A De Santis, F Cerini, A Farcomeni, ...
The American journal of gastroenterology 103 (11), 2738, 2008
Nutritional status: its influence on the outcome of patients undergoing liver transplantation
M Merli, M Giusto, F Gentili, G Novelli, G Ferretti, O Riggio, SG Corradini, ...
Liver International 30 (2), 208-214, 2010
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation
G Carpino, S Morini, SG Corradini, A Franchitto, M Merli, M Siciliano, ...
Digestive and Liver Disease 37 (5), 349-356, 2005
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial
M Merli, F Salerno, O Riggio, R de Franchis, F Fiaccadori, P Meddi, ...
Hepatology 27 (1), 48-53, 1998
Modification of cardiac function in cirrhotic patients with and without ascites
V Valeriano, S Funaro, R Lionetti, O Riggio, G Pulcinelli, P Fiore, A Masini, ...
The American journal of gastroenterology 95 (11), 3200, 2000
Branched-chain amino acids vs lactulose in the treatment of hepatic coma
F Rossi-Fanelli, O Riggio, C Cangiano, A Cascino, D De Conciliss, ...
Digestive diseases and sciences 27 (10), 929-935, 1982
Basal energy production rate and substrate use in stable cirrhotic patients
M Merli, O Riggio, A Romiti, F Ariosto, L Mango, G Pinto, M Savioli, ...
Hepatology 12 (1), 106-112, 1990
Sarcopenia from mechanism to diagnosis and treatment in liver disease
S Dasarathy, M Merli
Journal of hepatology 65 (6), 1232-1244, 2016
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
O Riggio, A Masini, C Efrati, F Nicolao, S Angeloni, FM Salvatori, M Bezzi, ...
Journal of Hepatology 42 (5), 674-679, 2005
Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice
S Angeloni, C Leboffe, A Parente, M Venditti, A Giordano, M Merli, ...
World journal of gastroenterology: WJG 14 (17), 2757, 2008
Malnutrition is a risk factor in cirrhotic patients undergoing surgery
M Merli, G Nicolini, S Angeloni, O Riggio
Nutrition 18 (11-12), 978-986, 2002
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial
M Cavallin, PS Kamath, M Merli, S Fasolato, P Toniutto, F Salerno, ...
Hepatology 62 (2), 567-574, 2015
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20